WCO classification path
- Chapter30Pharmaceutical products
- Heading3004Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (iincluding those in the form of transdermal administration systems) or in forms or packings for retail sale
- Subheading300460Other, containing antimalarial active principles described in Sub-heading Note 2 to this Chapter
- National30046010- - Containing artemisinin combined with other pharmaceutical active ingredients
30046010
"- - Containing artemisinin combined with other pharmaceutical active ingredients"
HS code 30046010 (Chapter 30 "Pharmaceutical products"; Heading 3004 "Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (iincluding those in the form of transdermal administration systems) or in forms or packings for retail sale"; Subheading 300460 "Other, containing antimalarial active principles described in Sub-heading Note 2 to this Chapter") under the Indonesia tariff schedule classifies "- - Containing artemisinin combined with other pharmaceutical active ingredients". Indonesia customs apply Import duty (MFN) of 5.00, VAT (PPN) 12.00. This commodity is subject to 7 import regulations or restrictions; see compliance section below. 19 free trade agreement preferential rates are available for this code.
Tariff Schedule
| Classification | Rate |
|---|---|
MFN 进口税 Import duty (MFN) | 5.00 |
增值税 (PPN) VAT (PPN) | 12.00 |
FTA Preferential Rates
19 agreements available · certificate of origin required
| Agreement | Rate |
|---|---|
| AANZFTA (ASEAN Australia New Zealand Free Trade Agreement) | 0% |
| ACFTA (ASEAN - China Free Trade Area) | 0% |
| AHKFTA (ASEAN-Hong Kong Free Trade Agreement) | 0% |
| AIFTA (ASEAN India Free Trade Agreement) | 0% |
| AJCEP (ASEAN-Japan Comprehensive Economic Partnership) | 0% |
| AKFTA (ASEAN Korea Free Trade Agreement) | 0% |
| ATIGA (ASEAN Trade in Goods Agreement) | 0% |
| IACEPA (Indonesia-Australia Comprehensive Economic Partnership Agreement) | 0% |
| ICCEPA (Indonesia-Chile Comprehensive Economic Partnership Agreement) | 0% |
| IECEPA (Indonesia-European Free Trade Association Comprehensive Economic Parthership) | 0% |
| IJEPA (Indonesia - Japan Economic Partnership Agreement) | 0% |
| IKCEPA (Indonesia-Korea Comprehensive Partnership Agreement) | 0% |
| RCEP-ASEAN (Regional Comprehensive Economic Partnership Agreement - ASEAN) | 0% |
| RCEP-Australia (Regional Comprehensive Economic Partnership Agreement - Australia) | 0% |
| RCEP-China (Regional Comprehensive Economic Partnership Agreement - China) | 0% |
| RCEP-Japan (Regional Comprehensive Economic Partnership Agreement - Japan) | 0% |
| RCEP-Korea (Regional Comprehensive Economic Partnership Agreement - Korea) | 0% |
| RCEP-New Zealand (Regional Comprehensive Economic Partnership Agreement - New Zealand) | 0% |
| IUAE-CEPA (Indonesia–United Arab Emirates Comprehensive Economic Partnership Agreement) | 1% |
Compliance & Controls
7 import regulations, restrictions, or permit requirements
Surat Keterangan Impor / Special Access Scheme (SAS)
- - Mengandung artemisinin dikombinasikan dengan bahan aktif farmasi lainnya
Surat Keterangan Impor / Special Access Scheme (SAS)
- - Mengandung artemisinin dikombinasikan dengan bahan aktif farmasi lainnya
Surat Keterangan Impor / Special Access Scheme (SAS)
- - Mengandung artemisinin dikombinasikan dengan bahan aktif farmasi lainnya
Surat Keterangan Impor / Special Access Scheme (SAS)
- - Mengandung artemisinin dikombinasikan dengan bahan aktif farmasi lainnya
Surat Keterangan Impor / Special Access Scheme (SAS)
- - Mengandung artemisinin dikombinasikan dengan bahan aktif farmasi lainnya
Surat Keterangan Impor / Special Access Scheme (SAS)
- - Mengandung artemisinin dikombinasikan dengan bahan aktif farmasi lainnya
Surat Keterangan Impor / Special Access Scheme (SAS)
- - Mengandung artemisinin dikombinasikan dengan bahan aktif farmasi lainnya
Global Benchmark
HS-6 prefix 3004.60 across other jurisdictions